HUPO 2022 World Congress

#HUPO 2022 Starts December 4, 2022

HUPO 2022 Speakers

Get to Know the Speakers

Meet the speakers for the HUPO 2022. In order to learn more about each individual speaker, please click on the photos below.

Main Congress Speakers

Steve Pennington

Categories: Award Winners, Main Congress Speakers
Steve Pennington: Ireland

Steve is Professor of Proteomics at the UCD School of Medicine & Conway Institute in Dublin, Ireland. He graduated from Imperial College, London (Chemistry and Biochemistry) before completing a PhD in Biochemistry at the University of Cambridge. He was elected President of HUPO (www.hupo.org) (2019-2021) and recently received HUPO’s biennial distinguished service award. He is also the founder of the UCD spin out company Atturos (www.atturos.com).

Steve Pennington

Click To Read Bio

Prof. Ying Ge

Categories: Award Winners, Main Congress Speakers
Prof. Ying Ge: USA

Dr. Ying Ge is a Professor in the Department of Cell and Regenerative Biology and Department of Chemistry at University of Wisconsin-Madison. She received a B.S. from Peking University and a Ph.D. from Cornell University under the joint supervision of Prof. Fred McLafferty and Prof. Tadhg Begley. After graduate school, Dr. Ge explored a career in pharmaceutical industry. In 2012, Dr. Ge started her tenure-track Assistant Professor position, received tenure in 2015, and was promoted to Full Professor in 2019. Ge’s research is highly interdisciplinary that cuts across the traditional boundaries of chemistry, biology, and medicine. It is her belief that to make significant impact in molecular medicine, it is necessary to combine technology with function and bridge the silos between basic and translational/clinical research for precision medicine. Dr. Ge has devoted her past twenty years to developing and applying top-down mass spectrometry-based proteomics to biomedical research. Recently her lab has developed a multi-pronged approach to address the challenges in top-down proteomics. Dr. Ge has published over 150 papers with many in high impact journals. She has received a number of awards such as the ASMS Biemann Medal (2020), HUPO Clinical and Translational Proteomics Award (2021), and HPLC Society Georges Guiochon Faculty Fellowship (2016), as well as The Top 100 Analytical Scientist Power List (on a global scale, 2019, 2020 2021). Dr. Ge is passionate about education and has been mentoring students from chemistry, biology and medicine.

Prof. Ying Ge

Click To Read Bio

Prof. Tony Purcell

Categories: Keynote Speakers, Main Congress Speakers
Prof. Tony Purcell: Australia
Tony is a NHMRC Principal Research Fellow and Deputy Head Department of Biochemistry at Monash University. He is also Vice President of the Australasian Proteomics Society, a HuPO council member and serves as a Scientific Advisory Board Member of the Human Proteome Project.
He is an Executive Advisory Board member of the journal Proteomics, an Associate Editor of Molecular Immunology and an Editorial Board Member of Molecular and Cellular Proteomics. He consults widely for industry and is on the Scientific Advisory Board of Evaxion Biotech and Bioinformatics Solutions.
His laboratory focusses on how the peptide antigens presented to the immune system, coined the immunopeptidome, is influenced by infection, inflammation and the environment. He has made important contributions to understanding the role of antigen in autoimmune diseases, drug hypersensitivity, cancer and infectious diseases. He is well known for work that has highlighted a role for post-translationally modified antigens in immunity. He has been instrumental in bringing new quantitative tools to immunological studies, in particular the quantitation of the cell surface expression levels of specific HLA-peptide complexes. He is a leader in the field of immunopeptidomics with over 270 related publications.

Prof. Tony Purcell

Click To Read Bio

Prof. Tadashi Yamamoto

Categories: Award Winners, Main Congress Speakers
Prof. Tadashi Yamamoto: Japan
Prof. Tadashi YAMAMOTO, the project leader of the Biofluid Biomarker Center (BBC), is a pioneer of proteomics of kidney diseases and urine biomarker discovery after engaging in the HUPO Human Kidney & Urine Proteome Project (HKUPP) in 2005. During his HKUPP chairmanship he introduced proteomics in nephrology and provided proteomics information in nephrology through the HKUPP website. He and BBC group have developed the protocols for proteomics of formalin-fixed paraffin-embedded human kidney biopsy tissues to understand pathophysiology of kidney diseases and of urine to discover biomarkers of kidney and urinary tract diseases by providing a standard guide for urine collection, and urine and kidney tissue proteome databases. Recently the biomarker discovery has been extended to all human diseases In collaboration with Tosoh Corporation by collecting more than 100,000 urine samples from patients with any diseases. He and his group have established a standard protocol for urine quantitative proteomics to measure approximately 2,000 urine proteins quantitatively for discovery of urine biomarkers of all human diseases. His goal is to provide a healthcare system, called “All-in-One Urine Tests”, to people for easy checkup of health conditions and early detection of diseases only by urine examination at home or office.

Prof. Tadashi Yamamoto

Click To Read Bio

Prof. Robert Moritz

Categories: Keynote Speakers, Main Congress Speakers
Prof. Robert Moritz: USA
Head,
Proteomics Research

Prof. Robert Moritz

Click To Read Bio

Prof. Jay Thelen

Categories: Keynote Speakers, Main Congress Speakers
Prof. Jay Thelen: USA
I earned my B.S. degree from the University of Nebraska-Lincoln in 1993 and my Ph.D. at the University of Missouri (MU) studying the regulation of the maize mitochondrial pyruvate dehydrogenase protein complex. In 1999 I began a postdoctoral position at Michigan State University investigating the regulation of plastid acetyl-CoA carboxylase (ACCase), a protein complex that catalyzes the committed step for de novo fatty acid synthesis. In 2002, I returned to MU to be the Associate Director of the Proteomics Center. Then in 2004 I joined the MU Biochemistry Department as an Assistant Professor and was promoted to Associate Professor in 2009 then Full Professor in 2016. My lab studies fatty acid biosynthesis in plants, specifically elucidating the unique regulatory properties of plant ACCase and leveraging these new discoveries to engineer higher oil in crops. Additionally, my research interests include plant metabolic regulation, seed development, protein phosphorylation, and quantitative proteomics approaches to study biological systems. I have authored over 140 publications, 5 patents, and founded a startup company. In 2011, I was awarded both the Presidential Early Career Award for Research Excellence and the Chancellor’s Award for Outstanding Research and Creative Activity from MU.

Prof. Jay Thelen

Click To Read Bio

Prof. Fuchu He

Categories: Award Winners, Main Congress Speakers
Prof. Fuchu He: China

Dr. He is the leading scientist studying proteomics in China. He was the founder of CNHUPO and among the first group of people who founded HUPO in 2001. He was the first Chinese scientist who led an international consortium-Human Liver Proteome Project (HLPP), and the founder of Beijing Proteome Research Center, Phoenix Center (proteomics) and Institutes of Biomedical Sciences Fudan University. As the chief scientist, he has been propelling HLPP to the China Human Proteome Project (CNHPP), to create an encyclopedia of proteins in the human body under physiological and pathological conditions. In 2019, his team stratified early hepatocarcinoma (HCC) into 3 proteomic subtypes with different clinical outcome. Some drug targetable proteins have been demonstrated useful in identifying patients with HCC who could potentially benefit from targeted treatment in further clinical trials. These studies demonstrated the proteomic analysis as an independent powerful tool in cancer molecular subtyping, indicating that the era of “Proteomics Driven Precision Medicine (PDPM)” is coming. He is currently proposing a world-wide project called π-HuB (The Proteomic Navigator of the Human Body). It aims at playing a central and catalytic role in biomedical research over the next several decades and providing an ultimate solution at the molecular level for health and well-being of the humankind.

Prof. Fuchu He

Click To Read Bio

Prof. Edward M. Marcotte

Categories: Keynote Speakers, Main Congress Speakers
Prof. Edward M. Marcotte: USA
Edward Marcotte is a Professor in the Department of Molecular Biosciences at the University of Texas at Austin, where he holds the Mr. and Mrs. Corbin J. Robertson, Sr. Regents Chair in Molecular Biology. He is an evolutionary biochemist whose research broadly uses tools of proteomics, bioinformatics, and systems and synthetic biology, with current work focused on the interactions, dynamics, and evolution of proteins across the tree of life. Marcotte has authored 230 journal publications and 22 issued/in process patents, received a National Institutes of Health Director’s Pioneer Award, is an elected Fellow of the Royal Society of Chemistry, the American Academy of Microbiology, and the American Association for the Advancement of Science, and co-founded the single-molecule protein sequencing company Erisyon, Inc.

Prof. Edward M. Marcotte

Click To Read Bio

Prof. Claudia Langenberg

Categories: Keynote Speakers, Main Congress Speakers
Prof. Claudia Langenberg: UK
Claudia Langenberg is Professor of Computational Medicine at the Berlin Institute of Health at Charité (BIH) and MRC Investigator and Programme Leader at the MRC Epidemiology Unit at the University of Cambridge. Her research is focused on the genetic basis of metabolic control, and her team studies its effects on health through integration of molecular with clinical data in large-scale patient and population-based studies.

Prof. Claudia Langenberg

Click To Read Bio

Prof. Claire Eyers

Categories: Keynote Speakers, Main Congress Speakers
Prof. Claire Eyers: UK
CLAIRE E. EYERS, BSC, PHD, FRSC – BIOSKETCH
Claire Eyers is a Professor of Biological Mass Spectrometry in the Institute of Systems, Molecular & Integrative Biology at the University of Liverpool (UoL), Director of the Centre for Proteome Research (CPR), and Associate Pro Vice Chancellor (Research & Impact) for the Faculty of Health and Life Sciences.
Having obtained a PhD (2002) in Biochemistry from the University of Dundee (Prof. Sir P. Cohen), she undertook postdoctoral studies at the University of Colorado, Boulder (Prof. N. Ahn) and then in the Michael Barber Centre for Mass Spectrometry, University of Manchester (Prof. S. Gaskell), where she became Acting Director (2009–2013). Her research exploits biophysical and biochemical methodologies to understand the structure and relevance of post-translational modifications (PTMs) and their roles in regulating cellular signalling in health and disease. She has established expertise in the development of mass spectrometric (MS)-based methods, and exploits separation technologies, including ion mobility spectrometry (IMS), for the structural investigation of proteins and the effects of PTMs and ligand binding.

Prof. Claire Eyers

Click To Read Bio

Prof. Chris Overall

Categories: Keynote Speakers, Main Congress Speakers
Prof. Chris Overall: Canada
Christopher Overall is a Tier 1 Canada Research Chair in Protease Proteomics and an Honorary Professor Albert-Ludwigs Universität Freiburg, Germany. He was inducted as a fellow into the Royal Society of Canada in 2018 and is Chair of the HUPO C-HPP. He is best known for his development of proteomic methodology for discovering protein N and C-termini and protease substrates in vivo, thereby establishing the field of terminomics, also known as degradomics. By generating clinically relevant insights into how proteases dampen disease-fighting defence systems involved in inflammation and immunodeficiency, degradomics has revealed a new layer of complexity in the hierarchy of cell and immune signalling regulation, revolutionizing our understanding of protease function and drug targeting. These insights led to the development of a new class of molecular correctors to treat MALT-1 protease deficiency and NF-kB activation in immunodeficiency disease. In the pandemic, Chris pivoted his laboratory to the investigation of SARS-CoV-2 proteases, revealing their drastic impact on cleaving hundreds of host cell proteins in critical pathways that promote the cellular takeover by the virus. His advances in proteomics have been recognized by the CNPN Tony Pawson Award (2014) and the 2018 HUPO Discovery Award. He is an Associate Editor of the Journal of Proteome Research.

Prof. Chris Overall

Click To Read Bio

Prof. Benjamin Garcia

Categories: Award Winners, Main Congress Speakers
Prof. Benjamin Garcia: USA

Benjamin A. Garcia obtained his BS in Chemistry at UC Davis in 2000, and then received his PhD in Chemistry in 2005 at the University of Virginia under Prof. Donald Hunt and then was an NIH NRSA Postdoctoral Fellow at the University of Illinois under Prof. Neil Kelleher from 2005-2008. From there Ben was appointed as an Assistant Professor in the Molecular Biology Department at Princeton University from 2008-2012, until his recruitment as the Presidential Associate Professor of Biochemistry and Biophysics at the University of Pennsylvania Perelman School of Medicine in 2012, promoted to full Professor in 2016, and named the John McCrea Dickson M.D. Presidential Professor in 2017. Ben moved in the summer of 2021 to the Washington University School of Medicine in St. Louis to become the Chair of the Department of Biochemistry and Molecular Biophysics. The Garcia lab has been developing and applying novel proteomic approaches and bioinformatics for interrogating protein modifications, especially those involved in epigenetic mechanisms such as histones during human disease, publishing over 350 publications. Ben has also been recognized with many honors and awards for his mass spectrometry research including The ASMS Biemann Medal and was named a Fellow of the Royal Society of Chemistry.

Prof. Benjamin Garcia

Click To Read Bio

Prof. Anne-Claude Gingras

Categories: Keynote Speakers, Main Congress Speakers
Prof. Anne-Claude Gingras: Canada

Anne-Claude Gingras is the Canada Research Chair in Functional Proteomics, the Lea Reichmann Chair in Cancer Proteomics and a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System. A Full Professor in the department of Molecular Genetics at the University of Toronto, she also serves as as deputy editor of Molecular and Cellular Proteomics and as a co-director of the Network Biology Collaborative Centre (a Genome Canada technology platform). Her lab focuses on the study of signalling pathways using systematic approaches and the development of quantitative proteomics technologies. She has developed computational tools that enable better analysis and visualization of proteomics results, and contribute to training the next generation of proteomics researchers. Using the tools that she developed, her group has identified new protein complexes and signaling components that provide a better understanding of perturbations associated with cancer and rare diseases. She also contributed to Canada’s response to the COVID-19 pandemic by developing high-throughput serology assays. Dr. Gingras has published >275 research articles and review articles that have already been cited 47K times.

Prof. Anne-Claude Gingras

Click To Read Bio

Prof. Amanda Hummon

Categories: Keynote Speakers, Main Congress Speakers
Prof. Amanda Hummon: USA

Prof. Amanda Hummon

Click To Read Bio

Prof. Alexey Nesvizhskii

Categories: Keynote Speakers, Main Congress Speakers
Prof. Alexey Nesvizhskii: USA
Alexey Nesvizhskii is the Godfrey Dorr Stobbe Professor of Bioinformatics in the Departments of Pathology and Computational Medicine & Bioinformatics, University of Michigan Medical School, Ann Arbor. His research laboratory (www.nesvilab.org) is working in the area of mass spectrometry based proteomics and proteogenomics, bioinformatics, and multi-omics data integration. Dr. Nesvizhskii’s research contributions include the development of concepts and computational methods implemented in many widely used bioinformatics tools, including PeptideProphet and ProteinProtein, CRAPome, SAINT, DIA-Umpire, MSFragger, IonQuant, Philosopher, and FragPipe (https://fragpipe.nesvilab.org/). His lab actively collaborates with technology developers, biologists, and clinical scientists. He has served on the Board of Directors for the American Society of Mass Spectrometry (ASMS), US HUPO, and on the Scientific Advisory Board for Swiss Institute of Bioinformatics. At the University of Michigan, Dr. Nesvizhskii directs the NCI-funded T32 Proteogenomics of Cancer Training Program and the University of Michigan Proteogenomics Data Analysis Center (UM-PGDAC; part of the Clinical Proteomic Tumor Analysis Consortium initiative). He also Directs the Proteomics Resource Facility which provides cutting-edge proteomics capabilities to UM investigators.

Prof. Alexey Nesvizhskii

Click To Read Bio

Nickki Packer

Categories: Award Winners, Main Congress Speakers
Nickki Packer: Australia

Prof Nicki Packer has had an extensive and varied research career in both Chemistry and Biological Sciences. She helped establish the Australian Proteome Analysis Facility (APAF) and co-founded Proteome Systems Ltd, a biotechnology company in which her group developed glycoanalytical technology and informatics tools. She has gained national and international recognition for her research in glycomics, using proteomics and bioinformatics approaches and linking it to biological functional research. Her current research is in the structure, function, informatics and application of glycans and their conjugates as molecular markers, focusing on their role in cancer, therapeutics and microbial infection. Nicki currently holds positions as Distinguished Professor of Glycoproteomics, and is a Chief Investigator in two ARC Centres of Excellence (NanoScale BioPhotonics and Synthetic Biology), is Academic Lead of APAF at Macquarie University, Sydney, and is a Principal Research Leader at the Institute for Glycomics, Griffith University, Australia. Her research role in all her work is directed towards the role of protein glycosylation in health and disease; specifically her current projects encompass the analysis and role of glycosylation in many systems including the i) function of glycans attached to glycoproteins and glycolipids, ii) cell membrane glycosylation interactions, iii) glycans as targets for bioimaging, diagnosis and drugs, iv) the mucin glycome-microbiome interactions. She has also raised three (reasonably well-balanced) children…..

Nickki Packer

Click To Read Bio

Mr. Oliver Raether

Categories: Award Winners, Main Congress Speakers
Mr. Oliver Raether: USA
Oliver Raether studied automation, measurement, control and feedback control engineering, optical- and environmental measurement and obtained in 1995 his Master of Science Degree from the Hamburg University of Technology in Germany.
In the same year Oliver Raether took up a position at Bruker Daltonik in Bremen Germany developing mobile gas chromatography and portable quadrupole mass spectrometers. Since 2000 Oliver initiated the development of orthogonal time of flight mass spectrometers as project manager and later from 2003 as research and development manager for orthogonal time of flight mass spectrometer. The Bruker micrOTOF, micrOTOF-Q (1st commercial TOF making use of an ion funnel), maXis, impact and compact products have been developed in his department.
Since 2010 Oliver Raether leads the development of the timsTOF product series.
Oliver Raether has co-authored 14 peer reviewed publications and is inventor/co-inventor of 20 patent families with 71 patents in the field of mass spectrometry (h-index 13).

Mr. Oliver Raether

Click To Read Bio

Marius Ueffing

Categories: Keynote Speakers, Main Congress Speakers
Marius Ueffing: Germany

Marius Ueffing has developed research strategies to combine bioanalytic, proteomic, functional genomics and computational research towards investigation of disease mechanisms and markers. His specific focus lies on the identifications of molecular mechanisms of disease as perturbation of protein networks, the identification of biomarkers for human neurodegenerative diseases and the identification of genes/proteins associated with neurological and retinal diseases.

He is the Director of the Institute for Ophthalmic Research at the University Medical Center in Tuebingen. He directs the Medical Proteome Center, a core facility of the medical faculty in Tübingen and has been a co-founder of QBiC, the Quantitative Biology Center of the University of Tuebingen. His previous positions included that of a Research Associate at Columbia University, College of Physicians and Surgeons, New York, followed by group leader positions in pharmaceutical industry at Goedecke-Parke-Davis and in the Division of Medical Genetics at the University Medical Centre Munich. Before and jointly with his appointment to Tübingen, he was Director of the Independent Research Unit/Division of Protein Science at the National Research Centre for Environment and Health in Munich. He has coordinated several research consortia funded by the  German government focusing on the development of proteomics technology as well as two EU consortia (EU 7thFW SYSCILIA and the EU Horizon2020 Systems Medicine Project EYE-RISK). In 2019 he received the HUPO Clinical and Translational Proteomics Award.

Marius Ueffing

Click To Read Bio

Marc Wilkins

Categories: Keynote Speakers, Main Congress Speakers
Marc Wilkins: Australia

In 1994 Marc Wilkins developed the concept of the proteome and coined the term. In 1997 he co-wrote and co-edited the first book on proteomics. Since that time, Marc has published >250 peer-reviewed research papers, review papers and book chapters and has edited 2 books in the field of proteomics, genomics and systems biology. In proteomics, a recent focus has been to construct a complete methylproteome network in a model organism, and to study its regulatory properties. In genomics, recent highlights have included the sequencing and assembly of the koala genome and collaborative work in the RNA atlas project.

In industry, Marc has co-founded two biotechnology companies. Proteome Systems Limited (1999), in which he worked for 6 years, was a proteomics diagnostics and technology development company. Regeneus (2007) is a regenerative medicine company that recently licensed its core product to a Japanese multinational. At UNSW, Marc is a Professor of Systems Biology. He has been Director of the Ramaciotti Centre for Genomics since 2011 and has grown that to be the largest such facility at any Australian university.

Marc is an elected member of the Council of HUPO, and was a co-organiser of HUPO2010 in Sydney and then HUPO2019 in Adelaide. Marc also serves as an elected member of the Australian Proteomics Society’s Committee of Management.

Marc Wilkins

Click To Read Bio

Ileana Cristea

Categories: Main Congress Speakers, Plenary Speakers
Ileana Cristea: USA

Ileana Cristea is the Henry L. Hillman Professor in Molecular Biology at Princeton University. Her laboratory investigates mechanisms of cellular defense during infection with human viruses. Towards this goal, she has promoted the integration of virology with proteomics and bioinformatics. She has developed methods for studying spatial and temporal virus-host protein interactions, bridging developments in mass spectrometry to important findings in virology. For example, her laboratory has contributed to the emergence of the research field of nuclear DNA sensing in immune response, to uncovering mechanisms underlying organelle remodeling and organelle structure-function relationships during infections, and to the discovery of sirtuins as broad-spectrum antiviral factors. Dr. Cristea is the Past-President of the American Human Proteome Organization (US HUPO), the past-chair of the Biology/Disease-driven Human Proteome Project (B/D-HPP) of HUPO, and the Chair of the Infectious Disease team of HUPO B/D-HPP. She has taught the summer Proteomics Course at Cold Spring Harbor Laboratory for over ten years, and is Senior Editor for mSystems, Associate Editor for the Journal of Proteome Research and on the Editorial Boards of Molecular Systems Biology and Molecular & Cellular Proteomics. She was recognized with the Bordoli Prize from the British Mass Spectrometry Society (2001), NIDA Avant-Garde Award for HIV/AIDS Research (2008), Human Frontiers Science Program Young Investigator Award (2009), Early Career Award in Mass Spectrometry from ACS (2011), ASMS Research Award (2012), Molecular Cellular Proteomics Lectureship (2013), Mallinckrodt Scholar Award (2015), Discovery Award in Proteomic Sciences at HUPO (2017), and the Princeton University Graduate Mentoring Award (2020).

 

Ileana Cristea

Click To Read Bio

György Marko Varga

Categories: Keynote Speakers, Main Congress Speakers
György Marko Varga: Sweden

The major research foci of György Marko-Varga are clinical studies, drug characterisation within Cancerous disease and Biobanking.

GYORGY is the Head of the European Cancer Moonshot Lund Center, with a focus on Melanoma and Lung Cancer.

Malignant Melanoma is the most frequently mutated tumor type with approx 50% of the cases harbor activating BRAF mutations, that is the key driver. Large scale studies are undertaken in multi-center studies, currently establishing the largest Molecular Pathology database with 700 patients and resulting 65 million sequence files, where most WHO Melanoma classes have been mapped and characterized.

We have developed digital pathology image libraries, establishing a morphology index pathology basis with a single cell annotation resolution, targeting clone specificificity of Melanoma cancer cell types, as well as stromal phenotypes that interplay and generates an initiation of the Metastasis spread.

ProteoGenomics expression on whole tumor sections, tumor compartments, and clone specific expressions are generated – adressing metastasis activation and developments, as well as mode-of-drug-action mechanisms, and the challenges realting to resistence and Cancer relapses.

Our major objective within the European Cancer Moonshot Center is to build medical knowledge on an individual patient basis by applying ProteoGenomics positioned in the heart of Cancer clinics, collaborating with oncologists, surgery and pathologists.

György Marko Varga

Click To Read Bio

Dr. Sameer Velankar

Categories: Main Congress Speakers, Plenary Speakers
Dr. Sameer Velankar: UK

PhD, Indian Institute of Science, 1997. Postdoctoral researcher, Oxford University, UK, 1997-2000. At EMBL-EBI since 2000.
More information on the team – https://www.ebi.ac.uk/about/teams/pdbe/

Dr. Sameer Velankar

Click To Read Bio

Dr. Ole Vorm

Categories: Award Winners, Main Congress Speakers
Dr. Ole Vorm: Denmark
Ole Vorm has worked with mass spectrometry of proteins since the late 1980’s and received his PhD from the University of Southern Denmark in 1995 after working in the labs of Prof. Peter Roepstorff and Prof. Matthias Mann. After a brief post.doc appointment at the EMBL in Heidelberg, Dr Vorm founded one of the worlds first dedicated proteomics companies, Protana in 1997 and joined MDS Proteomics in 2000 as it acquired Protana. In 2004 Dr. Vorm founded Proxeon that was acquired in 2010 by Thermo Fisher Scientific and from 2014 to 2016 Dr. Vorm served as VP of Proteomics at Bruker Inc. In March 2016, Dr. Vorm founded Evosep, in order to continue to work on ruggedising and simplifying sample handling and separation in connection with mass spectrometry. Dr. Vorm is a firm believer that proteomics will become a cornerstone of precision medicine in the near future and is working to contribute to the necessary technology components.

Dr. Ole Vorm

Click To Read Bio

Dr. Neil Kelleher

Categories: Keynote Speakers, Main Congress Speakers
Dr. Neil Kelleher: USA
Neil L. Kelleher, PhD is the director of the 50-person Proteomics Center of Excellence and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. His research is focused in the areas of top-down proteomics, natural products discovery, and cancer biology. Dr. Kelleher and his team drives both technology development and applications of very high performance mass spectrometry in proteomics and metabolomics. For bacteria and fungi, new platforms now feed compounds from the natural world into pharmaceutical pipelines.  In proteomics, Kelleher has emerged as a leading voice in a calling for an analogue of the Human Genome Project applied to human proteins.  This effort is called the Human Proteoform Project and has recently been endorsed by research consortia.  Neil is a serial entrepreneur with experience in spinning up four small companies, including a software shop providing the leading search engine used in >1000 labs for “top down proteomics”. His contributions to the fields of proteomics and natural products chemistry have been recognized by multiple awards, including the Biemann Medal from the American Society for Mass Spectrometry, the Pfizer Award in Enzyme Chemistry from the American Chemical Society, a Searle Scholar Award, a Packard Fellowship, and the Allen Distinguished Investigator Award.
Basic metrics for the Kelleher academic operation are:  H-factor ~75; >380 total publications; 50 Ph.D. students; >150 postdoctoral trainees.

Dr. Neil Kelleher

Click To Read Bio

Dr. Mikhail Savitski

Categories: Keynote Speakers, Main Congress Speakers
Dr. Mikhail Savitski: Germany
PhD in mass spectrometry at Uppsala university 2007. Group leader at Cellzome GSK from 2008-2015. Team leader and head of proteomics core facility at EMBL since 2016. The research group at EMBL develops novel proteomic technologies and applies them to study post-translational regulation.

Dr. Mikhail Savitski

Click To Read Bio

Dr. Melvin Park

Categories: Award Winners, Main Congress Speakers
Dr. Melvin Park: USA

Dr. Melvin Park is Director of Research at Bruker Daltonics. He received his bachelor’s degrees in Chemistry and Physics from NC State University in 1986 and a Ph.D. in Chemistry from Texas A&M in 1991. His dissertation centered on secondary ion mass spectrometry, coincidence counting, and time-of-flight mass spectrometry, and their application to surface analysis. After postdoctoral studies at the Naval Research Laboratories in 1993 regarding MALDI TOF, he joined Bruker. Over the past nearly three decades he and his colleagues have produced more than 80 issued patents and 30 peer reviewed journal articles in all areas of mass spectrometry and, more recently, ion mobility spectrometry. The most well-known of these is trapped ion mobility spectrometry (TIMS). His current work is the continued advancement and application of mass spectrometry, TIMS, and their peripherals.

Dr. Melvin Park

Click To Read Bio

Dr. Mathias Uhlen

Categories: Main Congress Speakers, Plenary Speakers
Dr. Mathias Uhlen: Sweden
Mathias Uhlen research is focused on protein science and precision medicine and ranges from basic research to more applied research, including clinical applications in cancer, infectious diseases, cardiovascular diseases, autoimmune diseases and neurobiology. He leads an international effort to systematically map the human proteome creating an open access resource the Human Protein Atlas (www.proteinatlas.org) with more than 15 million web pages and 10 million annotated bioimages. This resource is now one of the most visited life science databases in the world. His research has resulted in more than 750 publications with more than 80,000 citations and an h-index of 129 (Google Scholar). He is co-founder of 20 biotech companies of which five are publicly traded. He is member of the National Academy of Engineering (NAE) in USA, the Royal Swedish Academy of Science (KVA), the Swedish Academy of Engineering Science (IVA) and the European Molecular Biology Organization (EMBO). He was the Founding Director of the Science for Life Laboratory (SciLifeLab), a Swedish national center for molecular bioscience.

Dr. Mathias Uhlen

Click To Read Bio

Dr. Kiyoko Aoki-Kinoshita

Categories: Keynote Speakers, Main Congress Speakers
Dr. Kiyoko Aoki-Kinoshita: Japan

Glycoinformatics researcher since 2003, responsible for the glycan repository GlyTouCan, the glycomics MS repositories GlycoPOST (raw data) and UniCarb-DR (glycans), which are all accessible from the glycoscience Web portal GlyCosmos.

Dr. Kiyoko Aoki-Kinoshita

Click To Read Bio

Dr. Karin Rodland

Categories: Award Winners, Main Congress Speakers
Dr. Karin Rodland: USA
Dr. Karin Rodland joined the Biological Sciences Division at the Pacific Northwest National Laboratory in October 2001, after serving seventeen years on the faculty of Oregon Health Sciences University. As Chief Scientist for Biomedical Research at PNNL, she promoted the application of PNNL’s traditional strengths in mass spectrometry, proteomics, and systems biology to important problems in biomedical research. She served as the founding Director of the OHSU-PNNL Precision Medicine Innovation CoLaboratory, a joint effort dedicated to improving patient outcomes through the integration of cutting edge technologies in integrated omics, imaging, and data analysis to advance the goals of precision medicine.
Dr. Rodland’s own research focuses on signal transduction pathways that regulate proliferation in normal and malignant cells. Since joining PNNL, she has adopted a systems biology approach to signal transduction and has become a recognized expert in the field of proteomics and cancer biomarkers. She is a full member of the National Cancer Institute’s Early Detection Research Network and the Clinical Proteomics Tumor Analysis Consortium . She has served as Chair of the Cancer Biomarkers Study Section for the NIH, as well as the Department of Defense Congressionally Directed Medical Research Program Integration Panels for both Ovarian and Breast Cancer Research.

Dr. Karin Rodland

Click To Read Bio

Dr. Jennifer van Eyk

Categories: Keynote Speakers, Main Congress Speakers
Dr. Jennifer van Eyk: USA
Dr. Jennifer Van Eyk is currently the director of the Advanced Biosystems Research Institute at Cedars-Sinai Medical Center, LA and she also holds the inaugural Erika Glazer Endowed Chair in Women’s Heart Health. Dr. Van Eyk’s lab focuses on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods for the continuous assessments of cohorts focusing on health assessment. The Precision Biomarkers Laboratories, an outgrowth of her lab, is comprised of three independent commercial laboratories, aimed at facilitating the move from discovery to clinical assays for personalized biomarkers. Current, she is part of the Innovation Center, driving single cell phenotyping of patients samples for individualized therapy development.

Dr. Jennifer van Eyk

Click To Read Bio

Dr. Jean Armengaud

Categories: Keynote Speakers, Main Congress Speakers
Dr. Jean Armengaud: France

Jean Armengaud is specialized in mass spectrometry for biology and more specifically in proteogenomics and metaproteomics. He manages the ProGénoMIX platform located near Avignon in France. He wishes to contribute to a better understanding of the functioning of complex biological systems and exploit this knowledge for medical and environmental purposes. He received his PhD in Biochemistry in 1994 at the University of Grenoble.

Dr. Jean Armengaud

Click To Read Bio

Dr. Ben Collins

Categories: Award Winners, Main Congress Speakers
Dr. Ben Collins: Ireland

Since 2019 Ben is a Reader (equiv. Assoc. Prof.) in the the School of Biological Sciences, Queen’s University of Belfast, UK. His research focuses on broadly on 3 topics: (i) method development and applications in data independent acquisition mass spectrometry; (ii) method development and applications in the analysis of protein interaction networks and protein complexes; and (iii) applications of these strategies in host-pathogen biology and innate immunity. Ben’s PhD was completed at University College Dublin in 2009 where he remained for 1 year as the Agilent Technologies Newman Fellow (postdoctoral) in Quantitative Proteomics. Ben moved to the Institute of Molecular Systems Biology at ETH Zurich in Autumn 2010 as postdoctoral researcher under the supervision of Prof. Ruedi Aebersold, where his research focused on the application of quantitative interaction proteomics in signaling and the development of DIA/SWATH mass spectrometry. Following this Ben was a Group Leader and SNF Ambizione Fellow at IMSB, ETH Zurich with a focus on applying methods developed as a postdoc to relevant problems in host-pathogen biology.

Dr. Ben Collins

Click To Read Bio

Dr. Ashok Dongre

Categories: Keynote Speakers, Main Congress Speakers
Dr. Ashok Dongre: USA
Ashok Dongre is currently Scientific Director & Head of Proteomics in the Research & Early Development organization at Bristol Myers Squibb. He also manages the Genetically Modified Animal Alliances group.
Earned his B.Sc. & M.Sc. in Chemistry from University of Mumbai and Ph.D. in Analytical Chemistry (Vicki Wysocki) at Virginia Commonwealth University. Ph.D research led to the formulation of the “Mobile Proton Model” which elucidates peptide ion fragmentation mechanisms. Trained as HHMI post-doc at University of Washington with Alexander Rudensky & John Yates III.
Over 24-year tenure at BMS, his team is focused on innovating in proteomics space to address challenges at the intersection of disease pathophysiology and bio-pharmaceutical research. He served on NIH and NIAA review panels. He is a peer reviewer for several scientific journals.
Current research includes applying innovative methods to rapidly maturing novel therapeutic modality of Targeted Protein Degradation. This modality garners the potential to unlock the undruggable proteome bringing novel therapies to patients with unmet medical need. Group continues to elucidate innovative biomarker hypothesis across pathologies ranging from cancer to auto immunity and heart failure.
Authored / co-authored over 46 peer-reviewed scientific publications and numerous (>60) presentations. Three issued US Patents each with foreign equivalents.

Dr. Ashok Dongre

Click To Read Bio

Asst. Prof. Michael Angelo

Categories: Main Congress Speakers, Plenary Speakers
Asst. Prof. Michael Angelo: USA

Michael Angelo, MD PhD is a board-certified pathologist in the department of Pathology at Stanford University School of Medicine. Dr. Angelo is a leader in high dimensional imaging with expertise in tissue homeostasis, tumor immunology, and infectious disease. His lab has pioneered the construction and development of Multiplexed Ion Beam Imaging by time of flight (MIBI-TOF). MIBI-TOF uses secondary ion mass spectrometry and metal-tagged antibodies to achieve rapid, simultaneous imaging of dozens of proteins at subcellular resolution. His lab has used this novel technology to discover previously unknown rule sets governing the spatial organization and cellular composition of immune and stromal cells within the tumor microenvironment in triple negative breast cancer and ductal carcinoma in situ. This effort has led to ongoing work aimed to define broader structural mechanisms that promote tolerogenic niches in cancer, tuberculosis, and the maternal fetal interface. Dr. Angelo is the recipient of 2014 NIH Director’s Early Independence, 2020 DOD Era of Hope Award and is a principal investigator on multiple extramural awards from the National Cancer Institute, Breast Cancer Research Foundation, Parker Institute for Cancer Immunotherapy, the Bill and Melinda Gates Foundation, and the Human Biomolecular Atlas (HuBMAP) initiative.

Asst. Prof. Michael Angelo

Click To Read Bio

Asst. Prof. Justyna Fert-Bober

Categories: Keynote Speakers, Main Congress Speakers
Asst. Prof. Justyna Fert-Bober: USA

I am an Assistant Professor at Cedars-Sinai Heart Institute, with a broad background of biochemistry, molecular biology, immunology, and proteomics to study organ function and regulation in health and disease. My research involves inter-institutional collaborations focused on identifying novel and/or largely understudied biologic markers of heart failure (HF) with the major role of proteins posttranslational modifications (PTMs). I am pioneer in the understanding of arginine deiminases, enzymes family that introduce PTM, called citrullination and their contributions to many processes, like aging, inflammation, and their link with disease development and progression. Uncovering these biological bases are long term goals of my lab expanding to other physiological or pathological conditions. In fact, the COVID-19 pandemic experience has profoundly impact research at my lab and our work has been focuses on i) sex and race differences in both susceptibility and response to SARS-CoV-2 exposure and response to SARS-COV-2 infection; ii) sex and race differences in both positive and negative response to SARS-CoV-2 vaccine, and iii) linking adaptive immune response – autoimmunity with Long COVID, post-acute sequelae of SARS-CoV-2 infection. The concept of profiling autoantibodies in healthy and disease patients combined with multi-omic data will form the basis of disease prediction allowing for earlier intervention linked to disease prevention strategies, as well as earlier, effective and personalized interventions for established disease.

Asst. Prof. Justyna Fert-Bober

Click To Read Bio

Asst. Prof. Jennifer Geddes McAlister

Categories: Keynote Speakers, Main Congress Speakers
Asst. Prof. Jennifer Geddes McAlister: Canada

Dr. Jennifer Geddes-McAlister started her appointment as Assistant Professor in the Department of Molecular and Cellular Biology at the University of Guelph in July 2018. She is an expert in mass spectrometry-based proteomics following a Alexander von Humboldt post-doctoral fellowship at the Max Planck Institute of Biochemistry (Germany). Her research program aims to define the relationship between host and pathogen during infection to uncover new strategies for overcoming resistance in both medically- and agriculturally-relevant diseases. Dr. Geddes-McAlister is the elected Vice President, Communications and Board member for the Canadian National Proteomics Network (CNPN), co-Founder of the Canadian Proteomics and Artificial Intelligence Research and Training Consortium (CanProAI), and the elected Western Hemisphere Diversity Candidate for the Human Proteome Organization (HUPO). She recently founded ‘Moms in Proteomics’, an initiative dedicated to mentoring and supporting mothers in STEM and foudnded the CNPN Unity initiative to promote equity, diversity, and inclusion in proteomics research and training across Canada.

Asst. Prof. Jennifer Geddes McAlister

Click To Read Bio

Assoc. Prof. Ryan Kelly

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Ryan Kelly: USA
Ryan Kelly received his Ph.D. in analytical chemistry from Brigham Young University (BYU) in 2005 and spent the next 13 years at Pacific Northwest National Laboratory. He joined the Chemistry faculty of BYU as an Associate Professor in 2018. A central theme of Dr. Kelly’s research has been the development of new technological solutions for ultrasensitive biochemical analyses. He has developed ultra-low-flow electrospray ionization sources, improved MS ion optics and custom separations based on nanoflow liquid chromatography and capillary electrophoresis. Dr. Kelly’s efforts have recently focused on single-cell, spatial and other low-input MS-based proteomic analyses. His team developed the nanoPOTS workflow, which enables in-depth profiling of protein expression from single cells and makes possible high-resolution proteome imaging of tissues. His research continues to focus on improvements in sensitivity, throughput and quantification for single-cell proteomics and other sample-limited analyses. Dr. Kelly has authored or coauthored more than 100 publications and is a named inventor on several patents that have been licensed and commercialized by companies including Bruker, Cellenion and MicrOmics Technologies. His work has been recognized with several awards including R&D 100 awards, the Georges Guiochon HPLC Faculty Fellowship and the HTC Innovation Award.

Assoc. Prof. Ryan Kelly

Click To Read Bio

Prof. Renã Robinson

Categories: Keynote Speakers, Main Congress Speakers
Prof. Renã Robinson: USA
Dr. Renã A. S. Robinson, Professor of Chemistry at Vanderbilt University and inaugural Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellow, received her B.S. in Chemistry with concentration in Business from the University of Louisville and Ph.D. in Analytical Chemistry from Indiana University under the mentorship of Professor David Clemmer. She developed proteomics methods to study aging in Drosophila (fruit flies) and continued working in aging as a Lyman T. Johnson Postdoctoral Fellow with Professor D. Allan Butterfield at the University of Kentucky. During this fellowship she began to focus on neurodegenerative disorders such as Alzheimer’s disease and received a UNCF/Merck Postdoctoral Fellowship.
Dr. Robinson joined the Department of Chemistry at the University of Pittsburgh as Assistant Professor in 2009 and moved to Vanderbilt University in 2017. She has a nationally and internationally recognized research program and is a leader in the field of proteomics for her work in aging, Alzheimer’s disease, and applications relevant to human health and disparities. Her laboratory is especially focused on using advancing proteomics and lipidomics technologies to further understanding of health disparities in Alzheimer’s disease. Dr. Robinson is a Co-Investigator of the Recruitment Innovations for Diversity Enhancements NIH Award to understand the effectiveness of storytelling as a recruitment tool into Alzheimer’s disease research. She is an active member of several organizations serving underrepresented students and professionals in STEM, and is the President of the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE) and the faculty advisor for the Nashville Student and Professional Chapter of NOBCChE.

Prof. Renã Robinson

Click To Read Bio

Assoc. Prof. Morten Thaysen-andersen

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Morten Thaysen-Andersen: Australia
A/Prof Morten Thaysen-Andersen heads the Analytical Glycoimmunology group at Macquarie University, Sydney, Australia. His research program aims to advance our understanding of the human innate immune system and immune-related diseases including microbial infections, inflammation and cancer. His team develops and applies powerful glycomics and glycoproteomics technologies using advanced mass spectrometry while also drawing on analytical tools in protein and carbohydrate chemistry and methods in immunology, structural biology and molecular biology to unravel glycobiological processes of the innate immune system.

Assoc. Prof. Morten Thaysen-andersen

Click To Read Bio

Assoc. Prof. Jens Michael Schroeder

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Jens Michael Schroeder: Germany
Dr. Schröder graduated in chemistry, received his diploma in chemistry 1976, and finished 1980 his Doctoral thesis in Organic Chemistry. 1979 he joined the Dpt. of Dermatology at the Kiel University as research assistant to study the role of neutrophils and chemotaxins in psoriasis. In 1984 he discovered in psoriatic scale extracts a novel chemotactic peptide, later named Interleukin 8 or CXCL-8. In 1994 Dr. Schröder was appointed as professor for the biochemistry of inflammation and became head of a Clinical Research Unit until his retirement in 2015. After discovery of the first human inducible peptide antibiotic beta-defensin-2 in 1997, again isolated from psoriatic scales, and the discovery of several other antimicrobial peptides from human skin, he became founder and thereafter speaker of the collaborative research center (SFB) “Molecular Mechanisms of Epithelial Defense” and later a co-founder of the Excellence Initiative “Inflammation at Interfaces”. 2011 he organized as co-chair a Gordon Research Conference on “Antimicrobial Peptides”. He has been a member of the editorial board of various international journals, received several prestigious awards and is member of the German National Academy of Sciences, Leopoldina.
He discovered or co-discovered several important molecules or its function, among them the chemokines IL-8, Gro-alpha, RANTES, Eotaxin, the antimicrobial peptides hBD-2, hBD-3, RNase-7, Psoriasin, cationic intrinsically disordered antimicrobial peptides (CIDAMPs) like Hornerin and Filaggrin-2, and the protease-inhibitors elafin, SPINK-9, SPINK-6, as well as chemotic lipids like 5-oxo-eicosanoids and a fungal diacylated urea. He contributed to the understanding of the role of ß-defensins as factors linking innate and adaptive immunity as well as understanding the role of cathelicidin in the psoriasis pathogenesis. He received the prestigious high risk “Reinhart-Koselleck”-grant of the DFG to investigate “resistance-avoiding antimicrobial principles of healthy human skin”.
Most of his discovered molecules were purified from lesional psoriatic scale extracts and subsequently characterized.

Assoc. Prof. Jens Michael Schroeder

Click To Read Bio

Assoc. Prof. Christine Vogel

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Christine Vogel: USA
Dr. Christine Vogel is a trained biochemist with a Master’s in Mathematical Biology and a PhD in Computational Structural Biology obtained from the University of Cambridge, with Drs. Cyrus Chothia and Sarah Teichmann. After post-doctoral work with Dr. Edward Marcotte (Univ. of Texas at Austin), she joined New York University as faculty in 2011. Her lab uses a combination of proteomics, transcriptomics, computational, and targeted approaches to investigate the regulation of protein expression under stress. Her work was recognized by the US Human Proteomics Organization with the 2017 Robert J. Cotter New Investigator Award. The work is funded by the NIH and Chan Zuckerberg Initiative.

Assoc. Prof. Christine Vogel

Click To Read Bio

Assoc. Prof. Andreas Mund

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Andreas Mund: Denmark
Andreas Mund is an associate professor in the clinical proteomics group of Professor Matthias Mann at the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen. He has a dual education profile with a degree in biotechnology engineering from the Anhalt University of Applied Sciences and a PhD in protein biochemistry from the University of Hamburg. His research focuses on the characterization of single cell identity and heterogeneity in tissue biobank samples by a combination of high parametric imaging, artificial intelligence, and ultrahigh sensitive proteomics. This ‘Deep Visual Proteomics (DVP)’ technology deciphers the spatial molecular dimension by quantifying thousands of proteins in an unbiased manner. DVP couples in an unbiased way the physiological features of cells as seen in the microscope with the actual protein signature to understand mechanisms of health and disease.

Assoc. Prof. Andreas Mund

Click To Read Bio

Anjali Seth

Categories: Keynote Speakers, Main Congress Speakers
Anjali Seth: France

Anjali Seth studied Physics and Chemistry in Paris. She obtained her PhD from Pierre and Marie Curie University for her research on magnetic nanoparticles for targeted drug delivery and imaging. She then moved to Oxford, UK, for a postdoctoral project on magnetic particles and ultrasound for cancer theranostics. In 2019, she joined Cellenion, a company specialized in the field of single-cell isolation, to develop and lead the single cell proteomics R&D department. Since then, she had the opportunity to participate in the advancement of the cutting-edge field of single cell proteomics analyses using mass spectrometry. In Cellenion, she focuses on developing tools to facilitate and automate sample preparation workflows prior to analysis. Cellenion is now collaborating with most of the key opinion leader in the field.

Anjali Seth

Click To Read Bio

Albert J.R. Heck

Categories: Main Congress Speakers, Plenary Speakers
Albert J.R. Heck: Netherlands

Albert J.R. Heck (Utrecht University, The Netherlands) is scientific director of the Netherlands Proteomics Centre. Heck’s group emphasizes on the development and applications of advanced mass spectrometry-based proteomics technologies. Heck introduced TiO2 and Ti4+-IMAC based technologies for phospho-enrichment. Heck pioneered the use of alternative proteases and hybrid peptide fragmentation techniques (e.g. EThcD, UVPD). His group also introduced 15N labeling in multicellular organisms and the cost-effective dimethyl labeling. Heck’s proteomics research focuses for a large part on cancer, stem cells and immunology. Besides the proteomics efforts, the group of Heck is also well known for its expertise in mass spectrometry based structural biology, using native mass spectrometry, cross-linking and/or HD exchange mass spectrometry. The Heck-lab developed dedicated instruments for the analysis of intact proteins and protein complexes, with most recently a new high-mass Orbitrap, a serious breakthrough for top-down proteomics and native mass spectrometry. Through the development of the XlinkX and PhoX workflows they also facilitated proteome wide cross-linking studies. In recent years he has also focused on analyzing biopharmaceuticals, and plasma glycoproteins and immunoglobulins.

Heck is recipient of the HUPO Discovery Award (2013), and the Proteomics Pioneer Award from the European Proteomics Association (EuPA, 2014). In 2016 he received the ACS Field and Franklin Award. In 2014 he became elected member of EMBO and the Royal Netherlands Academy of Sciences and Arts (KNAW). In 2017 Heck received the Spinoza Prize, the most distinguished scientific award in the Netherlands. In 2018 Heck received the Thomson medal of the International Mass Spectrometry Society and the Krebs medal (FEBS), in 2021 the Pittcon Wallace H. Coulter Award.

Albert J.R. Heck

Click To Read Bio

Pre-Congress Speakers

Prof. Martin Larsen

Categories: Pre Congress Speakers, Pre Congress Training Course
Prof. Martin Larsen: Denmark
Professor Martin R. Larsen (MRL) is internationally recognized for development of method for the characterization of post-translational modifications (PTMs) of proteins in cell signaling and in bridging biological mass spectrometry and biomedical research. He coined the term “Phosphoproteomics” in 2001 and have developed some of the most superior methods within the field of PTMomics. Recently, MRL has developed the most comprehensive method for assessing PTMs such as phosphorylation, glycosylation, acetylation and reversible cysteine modifications from minute amount of sample. This method he used to characterize glucose-stimulated beta-cells, signaling in beta-cells derived from db/db mice, to reveal novel signaling processes associated with synaptic transmission in neurons and to study early brain development using brain organoids. The above-mentioned methods have been instrumental in the development of the growing field of PTMomics and MRLs role in developing this field was recognized by a Danish Elite Research award in 2014. MRL has published more than 230 scientific peer reviewed articles which has been cited more than 12000 times and he has an H-index of 54. MRL served in the HUPO board 2009-2019 and was chair of the HUPO award committee 2014-2019. MRL has held 13 EMBO practical workshops on PTM analysis.

Prof. Martin Larsen

Click To Read Bio

Prof. Manuel Mayr

Categories: Pre Congress Speakers, Pre Congress Training Course
Prof. Manuel Mayr: UK

Manuel Mayr is the British Heart Foundation (BHF) Professor for Cardiovascular Proteomics. He qualified in Medicine from the University of Innsbruck (Austria) in 1999. He then moved to London to undertake a PhD on combining proteomics and metabolomics. Upon completion of his PhD in 2005, he achieved promotion to Professor at King’s College London in 2011. In 2017, he has been awarded a BHF Personal Chair.

His group uses proteomics in combination with other -omics technologies to integrate biological information in disease-specific networks that drive pathophysiological changes. While studying molecular interactions has been a research focus for many years and has provided important insight into biology, the attention has now shifted towards a more integrative network biology approach (Nat Rev Cardiol. 2021;18(5):313-330). He has published more than 275 peer review scientific papers. He is Consulting Editor for JMCC and Circulation, Associated Editor for Atherosclerosis and Cardiovascular Research and serves on the editorial boards of Circ Res, ATVB and Mol Cell Proteomics.

His academic achievements have been recognised by the inaugural Michael Davies Early Career Award of the British Cardiovascular Society (2007), the inaugural Bernard and Joan Marshall Research Excellence Prize of the British Society for Cardiovascular Research (2010), the Outstanding Achievement Award by the European Society of Cardiology (ESC) Council for Basic Cardiovascular Science (2013) and most recently the President’s Distinguished Lecture of the International Society for Heart Research (ISHR, 2022).

Prof. Manuel Mayr

Click To Read Bio

Prof. Lisa Jones

Categories: Pre Congress Speakers, Pre Congress Training Course
Prof. Lisa Jones: USA

Lisa M. Jones is a Professor in the Department of Chemistry and Biochemistry at the University of California San Diego. She received her BS from the Department of Chemistry at Syracuse University and her PhD in Chemistry from Georgia State University. She received postdoctoral training in structural virology at the University of Alabama- Birmingham and in MS-based protein footprinting at Washington University in St. Louis. Dr. Jones’s research interests include the use of the protein footprinting method fast photochemical oxidation of proteins (FPOP) coupled with mass spectrometry for the characterization of the higher order structure of proteins. In particular, her lab has further developed the FPOP method for in-cell (IC-FPOP) studies for proteome-wide structural biology. Biological applications of IC-FPOP include characterizing protein folding intermediates directly in the cell and drug target (both on and off targets) determination. The Jones lab has also extended the method for in vivo analysis (IV-FPOP) in C. elegans. This provides the ability to study protein structure in an animal model for human disease.

Prof. Lisa Jones

Click To Read Bio

Prof. John Yates

Categories: Pre Congress Speakers, Pre Congress Training Course
Prof. John Yates: USA
John R. Yates is the Ernest W. Hahn Professor in the Departments of Molecular Medicine and Neurobiology at Scripps Research. His research interests include development of integrated methods for tandem mass spectrometry analysis of protein mixtures, bioinformatics using mass spectrometry data, and biological studies involving proteomics. He is the lead inventor of the SEQUEST software for correlating tandem mass spectrometry data to sequences in the database and developer of the shotgun proteomics technique for the analysis of protein mixtures. His laboratory has developed proteomic techniques to analyze protein complexes, posttranslational modifications, organelles and quantitative analysis of protein expression for the study of biology. He has received awards including the ASMS Biemann Medal, HUPO Achievement Award, Christian Anfinsen Award (Protein Society), Analytical Chemistry award (ACS), Ralph N. Adams Award, Thomson Medal (IMSF), John B. Fenn Award (ASMS), HUPO Discovery Award. He is currently the EIC at the Journal of Proteome Research.

Prof. John Yates

Click To Read Bio

Hugo Lopez-Fernandez

Categories: Pre Congress Speakers, Pre Congress Training Course
Hugo Lopez-Fernandez: Spain

I obtained a Computer Science degree in 2011 and a PhD in 2016 working in the field of Artificial Intelligence applied to the analysis of mass spectrometry data at Universidade de Vigo, under Dr. Daniel Glez-Peña and Dr. Miguel Reboiro-Jato supervision. The combination of Artificial Intelligence with Life sciences (especially Bioinformatics) defines my main research line since then. I have being member of the SING research group (Next Generation Computer Systems Group) since 2012 and I am currently working as Postdoctoral Researcher at the Informatics Department of Universidade de Vigo. I collaborate with the Phenotypic Evolution research group at Instituto de Investigação e Inovação (Porto, Portugal), where I worked as Junior Researcher between May and December 2021. I am also specialized in the development of scientific software applications (mainly in Java) and data analysis (R, Python), with special interest on the creation of automated analysis pipelines.

Hugo Lopez-Fernandez

Click To Read Bio

Dr. Isabell Bludau

Categories: Pre Congress Speakers, Pre Congress Training Course
Dr. Isabell Bludau: Germany

Isabell Bludau is a postdoctoral fellow in the lab of Prof. Matthias Mann at the Max Planck Institute of Biochemistry near Munich. She is specialized in computational proteomics and systems biology. During her PhD with Prof. Ruedi Aebersold at ETH Zurich, Isabell developed computational methods for analyzing large-scale proteomics data. She specifically worked on the detection and quantification of protein complexes and the inference of proteoform groups from bottom-up proteomics data. Recently, Isabell’s work focuses on investigating post-translational modifications in their 3-dimensional context. Isabell’s PhD thesis was awarded with the ETH silver medal and her postdoctoral research is supported by a Postdoc.Mobility fellowship of the Swiss National Science Foundation. Next to her research, Isabell is a member of the organizing committee of the ISCB’s Community of Special Interest on Computational Mass Spectrometry and she is part of the HUPO Early Career Researcher Initiative.

Dr. Isabell Bludau

Click To Read Bio

Asst. Prof. Sarah Parker

Categories: Pre Congress Speakers, Pre Congress Training Course
Asst. Prof. Sarah Parker: USA
Sarah Parker completed her PhD in Physiology in 2011 from the Medical College of Wisconsin, where she first began training in Mass Spectrometry and Proteomics with Dr. Andrew Greene. She then completed a Post Doctoral Fellowship with Dr. Jennifer Van Eyk at Johns Hopkins University, including a 3 month Fellowship working in Reudi Aebersold’s lab at ETH to learn the DIA-SWATH pipeline. Sarah began her faculty position at Cedars-Sinai in 2018 where she runs an Academic lab utilizing proteomics to study mechanisms and biomarkers of aneurysm and atherosclerosis. She has also recently taken on the role of Co-Director for the CSMC Proteomics and Metabolomics Core Facility. She has published on a range of proteomics projects, mostly incorporating DIA-MS and MRM techniques for protein identification and quantification.

Asst. Prof. Sarah Parker

Click To Read Bio

Assoc. Prof. Nikolai Slavov

Categories: Pre Congress Speakers, Pre Congress Training Course
Assoc. Prof. Nikolai Slavov: USA
Nikolai Slavov’s group seeks principles in the coordination among protein synthesis, metabolism, cell growth and differentiation. The Slavov group has pioneered multiplexed mass-spectrometry methods for quantifying proteins in single cells and is developing new computational methods for analyzing and understanding single-cell proteomics and multimodal data. The group obtained direct evidence for a new regulatory mechanism of protein synthesis (ribosome specialization) and continues to drive research in this emerging field supported by the NIH Director’s New Innovator Award. Dr. Slavov studied biology and physics at MIT before completing a dissertation at Princeton University (Botstein laboratory) with research focused on the coordination among metabolism, growth and gene expression. He then returned to MIT (van Oudenaarden laboratory) for post-doctoral research that characterized trade-offs of aerobic glycolysis.

Assoc. Prof. Nikolai Slavov

Click To Read Bio

Assoc. Prof. Daniel Kolarich

Categories: Pre Congress Speakers, Pre Congress Training Course
Assoc. Prof. Daniel Kolarich: Australia
Daniel is an ARC Future Fellow and leading the glycomics/glycoproteomics initiative at the ACRF International Centre for Cancer Glycomics, Institute for Glycomics, Griffith University in Queensland, Australia. His research interest is in understanding the glyco-language and its variations involved in cancer, immunity and infectious diseases. He and his team have been developing and applying cutting-edge glycomics and glycoproteomics for clinical applications and integrating glycomics and glycoproteomics data into integrated multi-omics workflows.
His career took him from Vienna to Macquarie University, Sydney, before starting his independent career in 2010 as a group leader at the Max Planck Institute for Colloids and Interfaces, Germany. Daniel returned to Australia in 2017 to establish and lead a new cancer and infectious disease glycomics and glycoproteomics laboratory at the Institute for Glycomics, Griffith University. These efforts have made it possible that in 2022, supported by multi-million investment from the Australian Cancer Research Foundation (ACRF) and Griffith University, the new ACRF International Centre for Cancer Glycomics could be established. This unique facility provides a bridge between basic and applied medical research with a specific focus on carbohydrates, the fourth major class of biomolecules essential for life.

Assoc. Prof. Daniel Kolarich

Click To Read Bio

Assoc. Prof. Cheng Chang

Categories: Pre Congress Speakers, Pre Congress Training Course
Assoc. Prof. Cheng Chang: China

Cheng Chang received his B.E. in Electronic Engineering from Hunan University, China, in 2010 and received in his Ph.D. in Bioinformatics from Beijing Proteome Research Center, China, in 2015. Currently, he is an associate research fellow in Department of Biomedical Big Data, Beijing Proteome Research Center and National Center for Protein Sciences (Beijing). His major research interests include proteomics, bioinformatics, and precision medicine.

Assoc. Prof. Cheng Chang

Click To Read Bio

Assoc. Prof. Birgit Schilling

Categories: Pre Congress Speakers, Pre Congress Training Course
Assoc. Prof. Birgit Schilling: USA
Dr. Birgit Schilling works at the Buck Institute for Research on Aging in the San Francisco Bay Area since 2000, where she has her own lab as Associate Professor and is Director of the Mass Spectrometry Technology Center. Dr Schilling is interested in translational research and any research that may aim towards therapeutic interventions to improve human aging or disease. Dr. Schilling’s uses modern proteomics technologies, such as data-independent acquisitions to investigate basic mechanisms of aging, as well as using this knowledge to develop biomarkers of aging and disease. Additional key projects in the lab investigate the dynamic role of post-translational modifications (PTMs) during signaling and specifically in the context of metabolic diseases, neurodegenerative diseases, cancer and aging. Combination of data-independent acquisitions with PTM research has allowed to gain better understanding for modification site localization and PTM crosstalk.

Assoc. Prof. Birgit Schilling

Click To Read Bio

Sponsored Content